Published in J Immunol on January 01, 1989
Neutrophil-activating peptide-1/interleukin 8, a novel cytokine that activates neutrophils. J Clin Invest (1989) 10.59
Chemotactic factors regulate lectin adhesion molecule 1 (LECAM-1)-dependent neutrophil adhesion to cytokine-stimulated endothelial cells in vitro. J Clin Invest (1991) 2.77
Red blood cells are a sink for interleukin 8, a leukocyte chemotaxin. J Clin Invest (1991) 2.32
Production of interleukin-8 by human dermal fibroblasts and keratinocytes in response to interleukin-1 or tumour necrosis factor. Immunology (1989) 2.31
Expression of adhesion molecules and chemotactic cytokines in cultured human mesothelial cells. J Exp Med (1992) 2.15
Enhanced production of neutrophil-activating peptide-1/interleukin-8 in rheumatoid arthritis. J Clin Invest (1991) 2.04
Neutrophil migration across monolayers of cytokine-prestimulated endothelial cells: a role for platelet-activating factor and IL-8. J Cell Biol (1992) 1.76
Increased interleukin 8 expression in the colon mucosa of patients with inflammatory bowel disease. Gut (1996) 1.73
Elevated interleukin-8 levels in the urine of patients with urinary tract infections. Infect Immun (1993) 1.64
Lipopolysaccharides of Bacteroides intermedius (Prevotella intermedia) and Bacteroides (Porphyromonas) gingivalis induce interleukin-8 gene expression in human gingival fibroblast cultures. Infect Immun (1992) 1.49
IL-1 transcriptionally activates the neutrophil chemotactic factor/IL-8 gene in endothelial cells. Immunology (1990) 1.47
Chemokine gene expression and secretion by cytokine-activated human microvascular endothelial cells. Differential regulation of monocyte chemoattractant protein-1 and interleukin-8 in response to interferon-gamma. Am J Pathol (1994) 1.39
Increased gastric production of interleukin-8 and tumour necrosis factor in patients with Helicobacter pylori infection. J Clin Pathol (1995) 1.34
Neutrophil mucosal involvement is accompanied by enhanced local production of interleukin-8 in ulcerative colitis. Gut (1993) 1.33
Neutrophil chemoattractants generated in two phases during reperfusion of ischemic myocardium in the rabbit. Evidence for a role for C5a and interleukin-8. J Clin Invest (1995) 1.23
Eosinophil accumulation induced by human interleukin-8 in the guinea-pig in vivo. Immunology (1993) 1.23
Cytokine profiles of cultured microvascular endothelial cells from the human intestine. Gut (1998) 1.08
TNF-α induces vectorial secretion of IL-8 in Caco-2 cells. J Gastrointest Surg (2010) 0.92
Desensitisation of neutrophil responses by systemic interleukin 8 in cystic fibrosis. Thorax (1994) 0.91
Immunohistochemical expression of interleukin 8 in skin biopsies from patients with inflammatory acne vulgaris. Diagn Pathol (2007) 0.90
Lactoferrin inhibits the lipopolysaccharide-induced expression and proteoglycan-binding ability of interleukin-8 in human endothelial cells. Infect Immun (2002) 0.88
Interleukin-8 is a major neutrophil chemotactic factor derived from cultured human gingival fibroblasts stimulated with interleukin-1 beta or tumor necrosis factor alpha. Infect Immun (1992) 0.86
Effects of interleukin-8 on nonspecific resistance to infection in neutropenic and normal mice. Antimicrob Agents Chemother (1993) 0.85
Differential expression of pro-inflammatory cytokines and a pro-apoptotic protein in pelvic ileal pouches for ulcerative colitis and familial adenomatous polyposis. Tech Coloproctol (2008) 0.83
Cardioprotective and endothelial protective effects of [Ala-IL8]77 in a rabbit model of myocardial ischaemia and reperfusion. Br J Pharmacol (1991) 0.83
Roles of ERK and NF-kappaB in Interleukin-8 Expression in Response to Heat Shock Protein 22 in Vascular Smooth Muscle Cells. Korean J Physiol Pharmacol (2008) 0.82
Role of interleukin 8 on leucocyte-endothelial cell adhesion in intestinal inflammation. Gut (1996) 0.80
Peptidoglycan Up-Regulates CXCL8 Expression via Multiple Pathways in Monocytes/Macrophages. Biomol Ther (Seoul) (2015) 0.79
Biological activity of CXCL8 forms generated by alternative cleavage of the signal peptide or by aminopeptidase-mediated truncation. PLoS One (2011) 0.79
The role of CD18 in IL-8 induced dermal and synovial inflammation. Br J Pharmacol (1992) 0.79
Immunohistochemical studies on NAP-1/IL-8 in contact eczema and atopic dermatitis. Arch Dermatol Res (1992) 0.77
Interleukin-8 is not involved in the increased chemotactic activity of peripheral blood plasma during acute myocardial infarction. Basic Res Cardiol (1993) 0.77
Inhibition by new glucocorticoid antedrugs [16α, 17α-d] isoxazoline and [16α, 17α-d]-3'-hydroxy-iminoformyl isoxazoline derivatives of chemotaxis and CCL26, CCL11, IL-8, and RANTES secretion. J Interferon Cytokine Res (2013) 0.76
Leukocyte ABCA1 remains atheroprotective in splenectomized LDL receptor knockout mice. PLoS One (2012) 0.76
A peptide antibiotic from human skin. Nature (1997) 7.64
Isolation and characterization of human beta -defensin-3, a novel human inducible peptide antibiotic. J Biol Chem (2000) 6.19
Purification and partial biochemical characterization of a human monocyte-derived, neutrophil-activating peptide that lacks interleukin 1 activity. J Immunol (1987) 4.43
Disease concomitance in psoriasis. J Am Acad Dermatol (1995) 3.92
Cytokine RANTES released by thrombin-stimulated platelets is a potent attractant for human eosinophils. J Exp Med (1992) 3.20
Psoriasis of early and late onset: characterization of two types of psoriasis vulgaris. J Am Acad Dermatol (1985) 2.74
Evidence for two psoriasis susceptibility loci (HLA and 17q) and two novel candidate regions (16q and 20p) by genome-wide scan. Hum Mol Genet (1997) 2.48
Elafin: an elastase-specific inhibitor of human skin. Purification, characterization, and complete amino acid sequence. J Biol Chem (1990) 2.23
Elevated levels of NAP-1/interleukin-8 are present in the airspaces of patients with the adult respiratory distress syndrome and are associated with increased mortality. Am Rev Respir Dis (1992) 2.11
Structure determination of a human lymphocyte derived neutrophil activating peptide (LYNAP). Biochem Biophys Res Commun (1988) 2.10
Linkage analysis of human leukocyte antigen (HLA) markers in familial psoriasis: strong disequilibrium effects provide evidence for a major determinant in the HLA-B/-C region. Am J Hum Genet (1998) 2.09
Identification of C5ades arg and an anionic neutrophil-activating peptide (ANAP) in psoriatic scales. J Invest Dermatol (1986) 1.96
Localization of psoriasis-susceptibility locus PSORS1 to a 60-kb interval telomeric to HLA-C. Am J Hum Genet (2000) 1.86
The genetics of psoriasis. Arch Dermatol (1994) 1.84
Structural aspects of initial psoriatic lesions. Arch Dermatol Forsch (1974) 1.81
Localization of neutrophil-activating peptide-1/interleukin-8-immunoreactivity in normal and psoriatic skin. J Invest Dermatol (1991) 1.79
Mutations in cornea-specific keratin K3 or K12 genes cause Meesmann's corneal dystrophy. Nat Genet (1997) 1.75
Treatment of psoriasis with fumaric acid esters: results of a prospective multicentre study. German Multicentre Study. Br J Dermatol (1998) 1.67
Dose-effects of 8-methoxypsoralen and UVA in cultured human lymphocytes. Br J Dermatol (1978) 1.64
IL-1 alpha or tumor necrosis factor-alpha stimulate release of three NAP-1/IL-8-related neutrophil chemotactic proteins in human dermal fibroblasts. J Immunol (1990) 1.50
[Stimulation of epidermal DNA syntgesis through vitamin A acid]. Arch Klin Exp Dermatol (1968) 1.48
Skin tumors in the European PUVA Study. Eight-year follow-up of 1,643 patients treated with PUVA for psoriasis. J Am Acad Dermatol (1987) 1.42
[Safety margins in the excision of primary malignant melanoma. Proposals based on controlled clinical trials]. Hautarzt (2001) 1.42
Purification and partial biologic characterization of a human lymphocyte-derived peptide with potent neutrophil-stimulating activity. J Immunol (1988) 1.42
[Abnormal behavior of epidermal regeneration in patients with psoriasis vulgaris]. Arch Klin Exp Dermatol (1967) 1.39
[Merkel cell tumor of the skin]. Dtsch Med Wochenschr (1997) 1.38
[Cryofibrinogenemia caused by monoclonal anti-fibrinogen antibodies]. Dtsch Med Wochenschr (1996) 1.38
[Epidermal regeneration of guinea pig's ear following the tearing off of the horny layer. A radioautographic study]. Arch Klin Exp Dermatol (1967) 1.38
Cellular architecture of the stratum corneum. J Invest Dermatol (1971) 1.37
Treatment of severe psoriasis with fumaric acid esters: scientific background and guidelines for therapeutic use. The German Fumaric Acid Ester Consensus Conference. Br J Dermatol (1999) 1.34
Mast cells and macrophages in early relapsing psoriasis. Arch Dermatol Res (1985) 1.31
Quadrant distribution of dysplastic nevus syndrome. Arch Dermatol (1988) 1.28
Epidemiology and comorbidity of psoriasis in children. Br J Dermatol (2009) 1.27
What is the 'true' function of skin? Exp Dermatol (2002) 1.26
[Modification of epidermal differentiation by vitamin A acid. Electron microscopy study]. Arch Klin Exp Dermatol (1970) 1.25
[On DNA synthesis time in the human epidermis]. Arch Klin Exp Dermatol (1967) 1.25
[A new method for visualization of the stratum corneum]. Arch Klin Exp Dermatol (1970) 1.24
Initial events in psoriasis: quantitative assessment. Br J Dermatol (1973) 1.24
[Growth dynamics of epidermis and papillary bodies after local applications of vitamin A acid. Biometrical studies of the guinea pig ear]. Arch Klin Exp Dermatol (1968) 1.24
Mechanisms of parakeratosis. Br J Dermatol (1970) 1.22
Proliferative cells in the human sebaceous gland. Labelling index and regional variations. Acta Derm Venereol (1971) 1.21
Detection of circulating melanoma cells by specific amplification of tyrosinase complementary DNA is not a reliable tumor marker in melanoma patients: a clinical two-center study. J Clin Oncol (1997) 1.20
IL-4 induces eotaxin: a possible mechanism of selective eosinophil recruitment in helminth infection and atopy. J Immunol (1998) 1.20
Association of rare human papillomavirus types with genital premalignant and malignant lesions. J Infect Dis (1998) 1.19
Scanning chromosome 17 for psoriasis susceptibility: lack of evidence for a distal 17q locus. Hum Hered (1995) 1.17
Antileukoprotease in human skin: an antibiotic peptide constitutively produced by keratinocytes. Biochem Biophys Res Commun (1998) 1.17
Neutrophil-activating proteins in psoriasis. J Invest Dermatol (1992) 1.17
The genetics of psoriasis 2001: the odyssey continues. Arch Dermatol (2001) 1.14
Importance of human papillomaviruses for the development of skin cancer. Cancer Detect Prev (2001) 1.13
A classification of psoriasis vulgaris according to phenotype. Br J Dermatol (2007) 1.13
S100B protein detection in serum is a significant prognostic factor in metastatic melanoma. Oncology (1999) 1.12
Polymorphonuclear leukocyte chemotaxis in psoriasis: enhancement by self-activated serum. Br J Dermatol (1980) 1.10
Epithelial malignancies in organ transplant patients: clinical presentation and new methods of treatment. Recent Results Cancer Res (2002) 1.08
Acute inflammatory effects of a monocyte-derived neutrophil-activating peptide in rabbit skin. Immunology (1989) 1.08
Recombinant human tumor necrosis factor alpha lacks chemotactic activity for human peripheral blood neutrophils and monocytes. Biochem Biophys Res Commun (1988) 1.06
Psoriatic hyperplasia: some measurements. Br J Dermatol (1970) 1.05
Mapping of the gene encoding human beta-defensin-2 (DEFB2) to chromosome region 8p22-p23.1. Genomics (1997) 1.05
SDZ ASM 981: an emerging safe and effective treatment for atopic dermatitis. Br J Dermatol (2001) 1.03
Inflammatory properties of neutrophil-activating protein-1/interleukin 8 (NAP-1/IL-8) in human skin: a light- and electronmicroscopic study. J Invest Dermatol (1991) 1.03
[The columnar structure of the epidermis. Possible mechanism of differentiation]. Z Zellforsch Mikrosk Anat (1971) 1.02
[On the behavior of autoantibodies in bullous pemphigoid]. Hautarzt (1967) 1.01
Genomic organization, sequence, and transcriptional regulation of the human eotaxin gene. Biochem Biophys Res Commun (1997) 1.01
A family study of atopic dermatitis. Clinical and genetic characteristics of 188 patients and 2,151 family members. Arch Dermatol Res (1990) 1.01
Prognostic significance of serum S100B detection compared with routine blood parameters in advanced metastatic melanoma patients. Melanoma Res (1999) 1.00
Selective action of hydrocortisone on postmitotic epidermal cells in vivo. J Invest Dermatol (1976) 0.99
Corneodesmosin gene polymorphism demonstrates strong linkage disequilibrium with HLA and association with psoriasis vulgaris. Tissue Antigens (1999) 0.99
The CXC receptor 2 is overexpressed in psoriatic epidermis. J Invest Dermatol (1998) 0.99
Analysis of RUNX1 binding site and RAPTOR polymorphisms in psoriasis: no evidence for association despite adequate power and evidence for linkage. J Med Genet (2005) 0.97
Production and characterization of monoclonal antibodies against the novel neutrophil activating peptide NAP/IL-8. J Immunol (1989) 0.97
Generalized atrophic benign epidermolysis bullosa in 2 siblings complicated by multiple squamous cell carcinomas. Arch Dermatol (1998) 0.97
Growth stimulation of cultured postembryonic epidermal cells by vitamin A acid. J Invest Dermatol (1974) 0.97
[Action mechanism of vitamin A acid (tretinoin)]. Arch Dermatol Forsch (1971) 0.96
[On cell reduplication in the exocrine sweat glands before and after stripping]. Arch Klin Exp Dermatol (1967) 0.96
Eruptive vellus hair cysts and steatocystoma multiplex. variants of one entity? Br J Dermatol (1996) 0.96
PUVA-treatment of urticaria pigmentosa. Br J Dermatol (1978) 0.96
IgA-associated inhibition of polymorphonuclear leukocyte chemotaxis in neutrophilic dermatoses. J Invest Dermatol (1981) 0.96
Predictive value of serum S100B for monitoring patients with metastatic melanoma during chemotherapy and/or immunotherapy. Br J Dermatol (1999) 0.96
Oral 8-methoxypsoralen photochemotherapy of psoriasis. The European PUVA study: a cooperative study among 18 European centres. Lancet (1981) 0.95
Lesional elastase activity in psoriasis, contact dermatitis, and atopic dermatitis. J Invest Dermatol (1992) 0.95
Biological therapies in the systemic management of psoriasis: International Consensus Conference. Br J Dermatol (2004) 0.95
Fluorescein-isothiocyanate as a stain for keratinizing epithelia. Arch Dermatol Forsch (1971) 0.95
Leiomyomatosis cutis et uteri. Acta Derm Venereol Suppl (Stockh) (1979) 0.95
Complete remission of a radio-resistant cutaneous angiosarcoma of the scalp by systemic treatment with liposomal doxorubicin. Br J Dermatol (2002) 0.94
Altered polymorphonuclear leukocyte responses in psoriasis: chemotaxis and degranulation. Br J Dermatol (1983) 0.94
Photoinactivation of skin fibroblasts by fractionated treatment with 8-methoxypsoralen and UVA. J Invest Dermatol (1979) 0.94
[Autoradiographic analysis of the postmitotic cell transitions in the epidermis]. Arch Klin Exp Dermatol (1970) 0.94
Neutrophil-activating peptide 1/interleukin 8 mRNA expression and protein secretion by human monocytes: effect of cyclosporin A. Cytokine (1991) 0.94
The formation of epidermal cell columns. J Invest Dermatol (1974) 0.94
Safety and efficacy of 1 year of tacrolimus ointment monotherapy in adults with atopic dermatitis. The European Tacrolimus Ointment Study Group. Arch Dermatol (2000) 0.94
Differential sensitivities of purified human eosinophils and neutrophils to defined chemotaxins. Scand J Immunol (1989) 0.93
Lack of association between NOD2 3020InsC frameshift mutation and psoriasis. J Invest Dermatol (2001) 0.93
Antileukoprotease inhibits stratum corneum chymotryptic enzyme. Evidence for a regulative function in desquamation. J Biol Chem (1996) 0.92
Oral lichenoid reactions associated with amalgam: improvement after amalgam removal. Br J Dermatol (2003) 0.92
[Psoriasiforme reaction of the guinea-pig epidermis after topical application of vitamin A-acid]. Arch Klin Exp Dermatol (1969) 0.91
Low prevalence of the intrinsic form of atopic dermatitis among adult patients. Allergy (2006) 0.90
[Liberation of human leukocyte elastase by hypertonic saline baths in psoriasis]. Hautarzt (1989) 0.90
Treatment of severe psoriasis with anti-CD25 monoclonal antibodies. Arch Dermatol (2000) 0.90
[On the incorporation of 35S-labelled sulfate in the skin in psoriasis (in vitro). Contribution to the problem of epidermal acid mucopolysaccharides]. Arch Klin Exp Dermatol (1966) 0.90